Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
Phase 2/3
180
about 4.7 years
18–65
1 site in SC
What this study is about
This trial is testing whether two at-home treatments, smell training and non-invasive trigeminal nerve stimulation, can improve the sense of smell in people with long COVID. Participants will conduct daily at-home treatment sessions and attend trial visits to complete questionnaires over 12 weeks.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Active Smell Training (ST)
- 2.Placebo Smell Training (PBO)
- 3.Use Trigeminal Nerve Stimulation (TNS)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change in Olfactory-related Quality of Life from Baseline to 4 and 12 Weeks
Secondary: Change in Cognitive Function from Baseline to 4 and 12 Weeks, Change in Long COVID Symptoms from Baseline to 4 and 12 Weeks, Change in Sleep Quality from Baseline to 4 and 12 Weeks, Change in Symptoms of Anxiety from Baseline to 4 and 12 Weeks, Change in Symptoms of Depression from Baseline to 4 and 12 Weeks